ReviewPharmacological reports : PR2025
Tyrosine kinase 2 inhibitors in the therapy of inflammatory and autoimmune diseases.
Patryk Rzeczycki et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled ittrialcites it